Center Laboratories

TWO:4123 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$975.80 Million
NT$32.29 Billion TWD
Market Cap Rank
#8515 Global
#221 in Taiwan
Share Price
NT$43.75
Change (1 day)
-2.02%
52-Week Range
NT$30.60 - NT$49.35
All Time High
NT$236.72
About

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antituss… Read more

Center Laboratories (4123) - Total Liabilities

Latest total liabilities as of September 2025: NT$6.17 Billion TWD

Based on the latest financial reports, Center Laboratories (4123) has total liabilities worth NT$6.17 Billion TWD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Center Laboratories - Total Liabilities Trend (2006–2024)

This chart illustrates how Center Laboratories's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Center Laboratories Competitors by Total Liabilities

The table below lists competitors of Center Laboratories ranked by their total liabilities.

Liability Composition Analysis (2006–2024)

This chart breaks down Center Laboratories's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.51 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.31 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Center Laboratories's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Center Laboratories (2006–2024)

The table below shows the annual total liabilities of Center Laboratories from 2006 to 2024.

Year Total Liabilities Change
2024-12-31 NT$7.48 Billion +10.27%
2023-12-31 NT$6.79 Billion +14.33%
2022-12-31 NT$5.94 Billion -36.51%
2021-12-31 NT$9.35 Billion +29.26%
2020-12-31 NT$7.23 Billion -2.35%
2019-12-31 NT$7.41 Billion +50.87%
2018-12-31 NT$4.91 Billion -77.09%
2017-12-31 NT$21.43 Billion +47.47%
2016-12-31 NT$14.53 Billion +11.54%
2015-12-31 NT$13.03 Billion +386.21%
2014-12-31 NT$2.68 Billion +492.94%
2013-12-31 NT$451.94 Million -25.60%
2012-12-31 NT$607.42 Million +52.61%
2011-12-31 NT$398.01 Million +48.10%
2010-12-31 NT$268.74 Million -11.06%
2009-12-31 NT$302.16 Million -31.80%
2008-12-31 NT$443.09 Million +149.39%
2007-12-31 NT$177.67 Million -20.15%
2006-12-31 NT$222.51 Million --